XableCath's Peripheral Arterial Catheters Gets US Patent

XableCath, Inc., innovators of products designed to aid in the treatment of peripheral artery disease, announced that it has been granted a second US Patent, No. 9,826,995, covering its XableCath catheter. The patent specifically describes a catheter that controls tissue contact and has a rigid ring implement that opens a blood vessel occlusion by rotating the ring against the occlusion, thus clearing the vessel and providing access across the lesion.

Peripheral arterial disease (PAD) is a disease of the arteries that carry blood to the limbs. Diseased arteries narrow or are blocked, thereby restricting adequate blood flow to reach peripheral extremities beyond the obstruction. PAD is the major cause of limb amputations, affecting more than 200 million people worldwide -- including 27 million people in Europe and the United States. Most amputations can be prevented with appropriate treatment.

The XableCath support catheter is designed to treat PAD by facilitating over -the-wire passage through the true artery lumen enabling endovascular treatment options such as angioplasty, stenting, or atherectomy. XableCath technology is designed to modify atheroma edges facilitating rapid and safe passage across tough arterial lesions in the peripheral vascular.